Intrathecal baclofen therapy versus conventional medical management for severe poststroke spasticity: results from a multicentre, randomised, controlled, open-label trial (SISTERS).
| Author | |
|---|---|
| Abstract |
:
Intrathecal baclofen (ITB) is a treatment option for patients with severe poststroke spasticity (PSS) who have not reached their therapy goal with other interventions. |
| Year of Publication |
:
2018
|
| Journal |
:
Journal of neurology, neurosurgery, and psychiatry
|
| Date Published |
:
2018
|
| ISSN Number |
:
0022-3050
|
| DOI |
:
10.1136/jnnp-2017-317021
|
| Short Title |
:
J Neurol Neurosurg Psychiatry
|
| Download citation |
